If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Vadim Alexandre on SkinBio Therapeutics, Alan Green on 3 Small Caps and Darren Sinden on Macro
Vadim Alexandre, Head of Healthcare at SP Angel discusses: SkinBio Therapeutics (SBTX)
SkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made by Dr. Catherine O'Neill and Professor Andrew McBain. SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, protect skin models from infection and repair skin models. Proof of principle studies have shown that the SkinBiotix® platform has beneficial attributes applicable to each of these areas.
Alan Green CEO of Brand Communications talks about:
Feedback (FDBK)
Destiny Pharma (DEST)
Bidstack (BIDS)
(Interview starts at 11 minutes 36 seconds)
Darren Sinden, Market Analyst at Pepperstone Limited talks about:
The US China trade dispute, Brexit and macro economic figures out this week.
(Interview starts at 35 minutes 17 seconds)